| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
66,921,000 |
| Market
Cap: |
2.79(B) |
| Last
Volume: |
1,212,774 |
Avg
Vol: |
1,005,861 |
| 52
Week Range: |
$38.26 - $88.63 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co. provides diagnostic testing solutions under various brand names, including, among others, the following: Quidel®, QuickVue®, QuickVue+®, Sofia®, Triage®, Solana®, Virena®, MicroVue™, Lyra®, FreshCells™, D3®, FastPoint®, ReadyCells®, Super E-Mix™, InflammaDry®, AdenoPlus®, ELVIRA®, ELVIS® and Thyretain®. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
• – – |
2017-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
338 |
43,653 |
|
- |
|
| Bryant Douglas C |
President & CEO |
• • – |
2017-02-25 |
4 |
D |
$21.15 |
$8,714 |
D/D |
(412) |
280,306 |
|
- |
|
| Bryant Douglas C |
President & CEO |
• • – |
2017-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,097 |
280,718 |
|
- |
|
| Steward Randall J |
Chief Financial Officer |
• – – |
2017-02-24 |
4 |
D |
$21.15 |
$3,447 |
D/D |
(163) |
19,626 |
|
- |
|
| Steward Randall J |
Chief Financial Officer |
• – – |
2017-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
435 |
19,789 |
|
- |
|
| Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
• – – |
2017-02-24 |
4 |
D |
$21.15 |
$2,919 |
D/D |
(138) |
43,315 |
|
- |
|
| Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
• – – |
2017-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
326 |
43,453 |
|
- |
|
| Bryant Douglas C |
President & CEO |
• • – |
2017-02-24 |
4 |
D |
$21.15 |
$8,418 |
D/D |
(398) |
279,621 |
|
- |
|
| Bryant Douglas C |
President & CEO |
• • – |
2017-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,061 |
280,019 |
|
- |
|
| Bryant Douglas C |
President & CEO |
• • – |
2017-02-24 |
4 |
AS |
$21.11 |
$928,686 |
D/D |
(44,000) |
278,958 |
|
- |
|
| Bryant Douglas C |
President & CEO |
• • – |
2017-02-24 |
4 |
OE |
$8.50 |
$374,000 |
D/D |
44,000 |
322,958 |
|
- |
|
| Brown Thomas D |
Director |
– • – |
2017-02-15 |
4 |
OE |
$13.97 |
$130,354 |
D/D |
9,331 |
39,410 |
|
- |
|
| Tamerius John |
SVP, Strat & Ext Affairs |
• – – |
2017-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,243 |
25,783 |
|
- |
|
| Steward Randall J |
Chief Financial Officer |
• – – |
2017-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,670 |
19,354 |
|
- |
|
| Bryant Douglas C |
President & CEO |
• • – |
2017-02-05 |
4 |
D |
$19.15 |
$49,292 |
D/D |
(2,574) |
277,845 |
|
- |
|
| Bryant Douglas C |
President & CEO |
• • – |
2017-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,408 |
280,419 |
|
- |
|
| Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
• – – |
2017-02-05 |
4 |
D |
$19.15 |
$22,444 |
D/D |
(1,172) |
43,127 |
|
- |
|
| Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
• – – |
2017-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,403 |
44,299 |
|
- |
|
| Kroll Werner |
SVP, R&D |
• – – |
2017-02-05 |
4 |
D |
$19.15 |
$20,146 |
D/D |
(1,052) |
2,696 |
|
- |
|
| Kroll Werner |
SVP, R&D |
• – – |
2017-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,403 |
3,748 |
|
- |
|
| Tamerius John |
SVP, Strat & Ext Affairs |
• – – |
2017-02-02 |
4 |
D |
$19.15 |
$18,786 |
D/D |
(981) |
24,802 |
|
- |
|
| Polan Mary Lake Ph D |
Director |
– • – |
2016-12-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
24,585 |
0 |
|
- |
|
| Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
• – – |
2016-12-01 |
4 |
S |
$23.00 |
$62,376 |
D/D |
(2,712) |
41,896 |
|
- |
|
| Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
• – – |
2016-12-01 |
4 |
OE |
$15.28 |
$41,439 |
D/D |
2,712 |
44,608 |
|
- |
|
| Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
• – – |
2016-11-30 |
4 |
S |
$22.78 |
$1,307,845 |
D/D |
(57,288) |
41,896 |
|
- |
|
1127 Records found
|
|
Page 27 of 46 |
|
|
0.91 (2.14%) 
